Showing results (51-60 of 2,811) with videos related to
Sort By:
Pageof 282
Diabetes Technology & Therapeutics|June 30, 2016
Comparison of Two Continuous Glucose Monitoring Systems, Dexcom G4 Platinum and Medtronic Paradigm Veo Enlite System, at Rest and During ExerciseNadine Taleb, Ali Emami, Corinne Suppere, et al.Diabetes Technology & Therapeutics|August 14, 2015
Bolus Estimation--Rethinking the Effect of Meal Fat ContentSrinivas Laxminarayan, Jaques Reifman, Stephanie S Edwards, et al.Diabetes Technology & Therapeutics|August 14, 2015
Effect of Insulin Dilution on Lowering Glycemic Variability in Pump-Treated Young Children with Inadequately Controlled Type 1 DiabetesBeata Mianowska, Wojciech Fendler, Bartłomiej Tomasik, et al.Diabetes Technology & Therapeutics|October 26, 2013
A clinimetric study of outpatient diabetes consultations: the potential for telemedicine substitutionFarhad Fatehi, Leonard C Gray, Anthony W RussellDiabetes Technology & Therapeutics|November 15, 2013
Hospital readmission and emergency department use based on prescribing patterns in patients with severely uncontrolled type 2 diabetes mellitusPhillip H Lee, Andrea S Franks, Patrick B Barlow, et al.Diabetes Technology & Therapeutics|October 18, 2013
Improved metabolic control in pediatric patients with type 1 diabetes: a nationwide prospective 12-year time trends analysisKlemen Dovc, Sasa Starc Telic, Lara Lusa, et al.Diabetes Technology & Therapeutics|July 26, 2013
The effect of adjusting for baseline hypoglycemia when analyzing hypoglycemia data: a systematic analysis of 15 diabetes clinical trialsJunxiang Luo, Scott J Jacober, Melvin J Prince, et al.Diabetes Technology & Therapeutics|July 26, 2013
A novel adaptive-weighted-average framework for blood glucose predictionYouqing Wang, Xiangwei Wu, Xue MoDiabetes Technology & Therapeutics|July 26, 2013
System accuracy of blood glucose monitoring systems: impact of use by patients and ambient conditionsChristina Schmid, Cornelia Haug, Lutz Heinemann, et al.Diabetes Technology & Therapeutics|February 28, 2012
U-500 insulin as a component of basal bolus insulin therapy in type 2 diabetesJolene Brown Lowery, Amy C Donihi, Mary T KorytkowskiPageof 282